First Time Loading...
C

Curexo Inc
KOSDAQ:060280

Watchlist Manager
Curexo Inc
KOSDAQ:060280
Watchlist
Price: 11 980 KRW -0.33%
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Curexo Inc

Wall Street analysts forecast Curexo Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Curexo Inc is 20 400 KRW with a low forecast of 20 200 KRW and a high forecast of 21 000 KRW.

Lowest Forecast
Wall Street Target
20 200 KRW
69% Upside
Average Forecast
Wall Street Target
20 400 KRW
70% Upside
Highest Forecast
Wall Street Target
21 000 KRW
75% Upside
Lowest
Price Target
20 200 KRW
69% Upside
Average
Price Target
20 400 KRW
70% Upside
Highest
Price Target
21 000 KRW
75% Upside
Curexo Inc Competitors:
Price Targets
W
WINNER
Winner Group Enterprise PCL
18% Upside
ORS
Orsero SpA
76% Upside
R
RUCHINFRA
Ruchi Infrastructure Ltd
71% Upside
4162
Almunajem Foods Company SJSC
12% Downside
W
WINNER
Winner Group Enterprise PCL
18% Upside
ORS
Orsero SpA
76% Upside
R
RUCHINFRA
Ruchi Infrastructure Ltd
71% Upside
4162
Almunajem Foods Company SJSC
12% Downside
227840
Hyundai Corporation Holdings Co Ltd
85% Upside
SYY
Sysco Corp
17% Upside
CHEF
Chefs' Warehouse Inc
39% Upside

Revenue
Forecast

Revenue Estimate
Curexo Inc

For the last 8 years the compound annual growth rate for Curexo Inc's revenue is 13%. The projected CAGR for the next 2 years is 33%.

13%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Curexo Inc

The compound annual growth rate of Curexo Inc's operating income for the next 2 years is 310%.

N/A
Past Growth
310%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Curexo Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Curexo Inc's stock price target?
Price Target
20 400 KRW

According to Wall Street analysts, the average 1-year price target for Curexo Inc is 20 400 KRW with a low forecast of 20 200 KRW and a high forecast of 21 000 KRW.

What is Curexo Inc's Revenue forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for Curexo Inc's revenue is 13%. The projected CAGR for the next 2 years is 33%.

What is Curexo Inc's Operating Income forecast?
Projected CAGR
310%

The compound annual growth rate of Curexo Inc's operating income for the next 2 years is 310%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.